Numeric Investors’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Numeric Investors’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$207K	Buy	+8,000	New	+$161K	﹤0.01%	1029
2017 Q3	–	Sell	-60,200	Closed	-$840K	–	1220
2017 Q2	$840K	Buy	60,200 +8,400	+16%	+$124K	0.01%	717
2017 Q1	$884K	Sell	51,800 -407,581	-89%	-$4.89M	0.01%	676
2016 Q4	$4.73M	Sell	459,381 -123,872	-21%	-$1.13M	0.04%	339
2016 Q3	$5.9M	Sell	583,253 -35,345	-6%	-$386K	0.06%	290
2016 Q2	$6.95M	Buy	618,598 +117,019	+23%	+$1.49M	0.06%	264
2016 Q1	$6.85M	Sell	501,579 -29,558	-6%	-$425K	0.07%	248
2015 Q4	$10.1M	Buy	531,137 +483,247	+1,009%	+$10.5M	0.11%	197
2015 Q3	$899K	Buy	+47,890	New	+$814K	0.01%	574

Other funds holding CNCE

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Numeric Investors's CNCE Position: Q4 2017 in Review

Numeric Investors opened a new position in Concert Pharmaceuticals, Inc. (CNCE) in Q4 2017: 8,000 shares worth $207K. The stake represents ﹤0.01% of the portfolio and ranks #1029 among its holdings. This is a return to the name: Numeric Investors previously reported a position in CNCE as recently as Q2 2017.

Numeric Investors first reported a position in CNCE in Q3 2015 and has held it in 9 quarters since. The position peaked at $10.1M in Q4 2015. 114 funds tracked by Wall St. Rank hold CNCE as of Q4 2017.

Numeric Investors held 8,000 shares of Concert Pharmaceuticals, Inc. worth $207K as of Q4 2017.
Concert Pharmaceuticals, Inc. was a new Numeric Investors position in Q4 2017.
Concert Pharmaceuticals, Inc. made up ﹤0.01% of Numeric Investors's portfolio in Q4 2017, its #1029 holding.
Numeric Investors first reported a position in Concert Pharmaceuticals, Inc. in Q3 2015 and has held it in 9 quarters since.
Numeric Investors's Concert Pharmaceuticals, Inc. position peaked at $10.1M in Q4 2015.
114 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.